.0 T 0.8 kg; body mass index, 21.8 T 0.4 kgIm j2 ) completed a diet and exercise intervention over three menstrual cycles. Participants were randomized to groups that varied in the magnitude of negative energy balance created by the combination of exercise and energy restriction. Menstrual disturbances were determined using daily urinary estrone-1-glucuronide and pregnanediol glucuronide, midcycle luteinizing hormone, and menstrual calendars. In a secondary analysis, we calculated EA from energy balance data and tested the association of EA with MD. Results: A generalized linear mixed-effects model showed that the likelihood of a MD decreased by 9% for each unit increase in EA (odds ratio, 0.91; 95% confidence interval, 0.84-0.98; P = 0.010). No specific value of EA emerged as a threshold below which MD were induced. When participants were partitioned into EA tertile groups (low EA, 23.4-34.1; n = 11; moderate EA, 34.9-40.7; n = 12, and high EA, 41.2-50.1; n = 12 [kcalIkg j1 ffmId j1 ]), estrone-1-glucuronide (P G 0.001), pregnanediol glucuronide (P G 0.001), and luteal phase length (P = 0.031) decreased significantly, independent of tertile. Conclusions: These findings do not support that a threshold of EA exists below which MD are induced but do suggest that MD increase linearly as EA decreases. Menstrual disturbances can likely be prevented by monitoring EA using a simplified assessment of metabolic status.
xercise-associated menstrual disturbances (MD) are commonly observed in physically active women and female athletes. Prevalence rates vary depending on the type of exercise or sport but have been reported as luteal phase defects (29%), anovulation (20%), oligomenorrhea (7%), and amenorrhea (37%) (1, 2) . Clinical sequelae are well documented (3, 4) and include transient infertility (5) , low bone mineral density (6, 7) , a greater risk of stress fractures (8, 9) , and negative alterations in cardiovascular function (10) . Research in women and nonhuman primates on the underlying mechanism of exercise-related menstrual disorders has demonstrated the causal role of low energy availability (EA) in the induction and reversal of exerciseassociated MD (11) (12) (13) .
The suppression of reproductive function by low EA allows for a repartitioning of available energy from the nonessential functions of growth and reproduction toward the essential functions of thermoregulation, locomotion, and cellular maintenance (14) . In some studies of the effects of low EA on luteinizing hormone (LH) pulsatile secretion, EA has been represented with a particular index, that is, the difference between the total energy consumed as food and the energy expenditure of exercise normalized for fatfree mass (ffm) (15) . Short-term (5 d) reductions in EA below a threshold of 30 kcalIkg j1 ffmId j1 slowed the pulsatile release of LH, a proxy indicator of hypothalamic gonadotropic-releasing hormone) secretion from the anterior pituitary gland (16) . A slowing of LH pulse frequency is associated with delays in folliculogenesis and luteal phase shortening and complete menstrual suppression (17) (18) (19) . Reduced LH pulse frequency in response to low EA occurs whether EA is reduced through diet, exercise, or a combination of both (15) . When EA is reduced below 30 kcalIkg j1 ffmId
j1
, metabolic effects that have been observed include reduced serum concentrations of glucose, triiodothyronine, insulin, insulin-like growth factor-1, and increased concentrations of growth hormone and cortisol (15, 16) . Although these previous studies elegantly identified the importance of EA in the modulation of LH pulse frequency, the magnitude of change in EA that is associated with the induction of MD has not been directly demonstrated through experimentation.
We previously demonstrated that an energy deficit created by the combination of exercise and dietary restriction over three menstrual cycles results in MD in a dose-dependent manner, such that a greater energy deficit resulted in a greater frequency of MD (20) . Luteal phase defects, oligomenorrhea, and anovulation were induced by energy deficits that ranged from j22% to j42% of baseline energy needs and in absolute terms, j470 to j810 kcal below initial energy requirements (20) . These results provide practical information about the magnitude of the energy deficit that result in exercise-associated MD. However, the assessment of all the components of energy balance is difficult and expensive and thus not very practical.
Assessing EA as defined by Loucks et al. (15, 16 ) requires the assessment of 1) 24-h dietary intake, 2) exercise energy expenditure (EEE), and 3) FFM, all of which can be calculated by coaches or trainers in a field setting. Moreover, this particular calculation of EA has been recommended for the prevention and management of the female athlete triad (3, 21) . Although our previous work documented a causal role of an energy deficit in the induction of MD in exercising women, our results may be more useful if the energy deficit was expressed similarly to the Loucks et al. (15, 16) calculation of EA. Moreover, the induction of MD due to low EA has not been experimentally demonstrated.
The goal of this study was to determine whether low EA, as assessed using the Loucks et al. calculation (15, 16) , could induce MD and to explore whether these disturbances only occur below a specific threshold of EA. Another aim was to build on our previous work (20) by reporting the impact of low EA on the urinary concentrations of estrone-1-glucuronide (E1G) and pregnanediol glucuronide (PdG), which are proxy indicators of estradiol and progesterone. Taking advantage of the ability to examine the temporal relation between variables of interest, we also sought to determine whether EA in the previous menstrual cycle as well as in the current menstrual cycle was related to the occurrence of menstrual cycle disturbances. We hypothesized that the incidence of MD will be inversely related to EA, such that a lower EA will be associated with a higher incidence of MD. We also hypothesized that mean E1G and PdG will be linearly related to EA, such that a lower EA will be associated with lower concentrations of these metabolites.
METHODS Experimental Overview
Original study. This study is a secondary analysis of data collected in our previous study which used a randomized prospective design to examine the impact of a controlled feeding and supervised exercise intervention on the occurrence of MD among young, untrained, ovulatory women over the course of three menstrual cycles (20) . The latter is referred to as ''the original study,'' whereas this study is referred to as the ''current analysis.'' The intervention in the original study was initiated after a screening and baseline period. After the baseline cycle, participants were randomly assigned to their experimental groups. Four groups were created representing distinct levels of energy deficiency; one in which participants exercised but energy balance was maintained, and three other groups that represented low, moderate, and high energy deficits created by a combination of exercise and caloric restriction during the intervention. The intervention was subdivided into three menstrual cycles known as intervention cycle 1, 2, and 3 (INT 1, INT 2, and INT 3). Each of the three energy deficit groups (low, moderate, and high) exercised and was prescribed an individual energy intake so that the target negative energy balance ranged from j15% to j60% of baseline energy needs depending on the group. Each of the four study phases, that is, baseline, INT 1, INT 2, and INT 3 was the length of a given participant's menstrual cycle. A poststudy period of 1 wk where diet and exercise remained controlled allowed for postintervention measurements.
Current analysis. For the current secondary analysis, we used the energy balance data from the original study to calculate EA as described by Loucks et al. (15, 16) . Daily EA was calculated using that day's energy intake, net EEE, and the most recent measure of ffm as described below. The calculated energy deficit used in our previous study (20) and our calculated EA values were highly correlated (R = 0.88; P G 0.001). The average EA for each phase of the study (baseline, INT 1, INT 2, and INT 3) was calculated as was the EA for entire intervention (INT 1 to INT 3). These EA data were used in regression analyses. For other analyses, participants were grouped into tertiles based on their EA for the entire intervention, that is, low, moderate, or high EA. The low EA group consisted of participants whose average EA ranged from 23.4 to 34.1 kcalIkg j1 ffmId j1 , the moderate EA group consisted of participants whose average EA ranged from 34.9 to 40.7 kcalIkg j1 ffmId j1 , and the high EA group consisted of participants whose average EA ranged from 41.2 to 50.1 kcalIkg j1 ffmId j1 .
Experimental Methods in the Original Study
Participants. In the original study, inclusion criteria were as follows: 1) no history of serious medical conditions; 2) no current evidence of disordered eating or history of an eating disorder; 3) age, 18 to 30 yr, 4) weight, 45 to 75 kg; 5) body fat, 15% to 35%; 6) body mass index [BMI],18 to 30 kgIm j2 ; 7) nonsmoking; 8) no medication use that would alter metabolic hormone concentrations, for example, thyroid medication, glucose lowering drugs; 9) no significant weight loss/gain T2.3 kg (T5 lb) in the last year; 10) less than 1 h of purposeful aerobic exercise per week; 11) not taking hormonal contraceptives for the past 6 months; 12) documentation of at least two ovulatory menstrual cycles during screening. Participants were told the purpose, procedures, and potential risks of participation in the study before they provided their documented informed consent. The original consent was approved by the Penn State University Biomedical Institutional Review Board. Recruitment occurred over three consecutive academic years and were drawn from the university community during the fall semester of each academic year.
Screening and baseline. Each participant_s medical history, menstrual history (self-report, previous 6 months), current and past physical activity (22) , eating attitudes and behaviors, anthropometrics, and physical and psychological status were measured during the original study_s screening phase using previously published methods (23) . Screening occurred over two to three menstrual cycles. All participants completed a menstrual history questionnaire in which they were asked whether they had regular (26-35 d ) menstrual cycles during the previous 6 months, and before the previous 6 months. Participants were excluded if they had a history of MD and or were not eumenorrheic (26-35 d ) during the last 6 months. Over two screening cycles before the baseline period, the participants completed menstrual calendars to monitor menstrual cycle length, menstrual bleeding, and menstrual symptoms. Ovulation was assessed using ovulation detection kits processed in the laboratory on midcycle urine collections. Blood samples were collected via venipuncture during screening to rule out hormonal or metabolic disease. A physical examination was performed by a clinical research center (CRC) clinician, and a clinical interview was performed under the supervision of a clinical psychologist to rule out the history of or any current eating disorders. A CRC dietitian screened participants for inclusion in a controlled feeding study and instructed them on how to complete a 3-d food log. Menstrual status was assessed using self-reported menstrual calendars, ovulation detection kits (First Response, Tambrands, Inc.), and three midluteal phase serum progesterone measurements (at least one 95.0 ngImL j1 ) to indicate ovulation obtained via venipuncture during the baseline cycle (24) .
Assessment of baseline energy needs. Baseline energy needs were assessed during the early follicular phase of the baseline cycle. Twenty-four-hour energy expenditure was assumed to represent baseline energy needs because all participants were weight stable (T1.5 kg) during the study_s screening phase. Twenty-four-hour energy expenditure was assessed as the sum of resting metabolic rate (RMR) (kcal per 24 h) and the energy expended that were attributable to that day_s physical activity. Resting metabolic rate was measured during the follicular phase of the baseline cycle using indirect calorimetry. Expenditure because of physical activity was measured with an accelerometer (RT3; Stayhealthy, Monrovia, CA), where the device was worn 24 hId j1 , 7 dIwk j1 (except during training bouts, sleeping, swimming, and bathing), during the follicular phase. This sum (RMR kcal per 24 h and RT3 physical activity kcal per 24 h) was operationally defined as the participant_s baseline energy needs (25) . The quantity of food intake during baseline was adjusted if the participant_s body weight varied during a 1-wk ''calibration'' period (see below).
Determination of energy intake during the intervention. Energy intake for each participant assigned to the original study groups was calculated as the percentage change in baseline energy needs. All food consumed over the course of the study was prepared by CRC staff in a metabolic kitchen where food was weighed to the nearest gram to ensure the desired energy level. Energy content of prepared food items was verified with bomb calorimetry as previously described (26) . All participants were required to eat at least two of their three daily meals at the CRC dining room, whereas the other daily meal, all weekend meals, and a daily snack were packed out. The CRC dietary staff followed an 8-d meal rotation to ensure diet variety. The prescribed diet was comprised of 55% carbohydrates, 30% fat, and 15% protein. To ensure that the energy content of food reflected baseline energy needs, a 1-wk calibration period was initiated where T100 kcal adjustments were made if the participant_s weight changed more than T 0.5 kg during the week. After the baseline cycle, the energy content of prescribed food was adjusted according to the participant_s assigned group. Participants were instructed to eat all and only the foods provided to them. If participants were unable to eat all of the food provided, uneaten food was returned to the laboratory where it was weighed by a CRC dietitian, and the alteration in energy intake was taken into account. Participants were discouraged from eating food that had not been provided by the study. If participants did eat food that had not been provided, they were instructed to record what they consumed, and this amount was added to the calculation of dietary intake. Total intake for each day was analyzed for macronutrient composition and energy content with Nutritionist Pro (First Data Bank, Indianapolis, IN).
Exercise training. Exercise training took place at Noll Laboratory and was supervised by trainers. Aerobic exercise was performed once per day five times per week at 70% to 80% of maximum heart rate as determined from tests of maximal aerobic capacity (V O 2max ). The duration of exercise was dependent on the energy expenditure prescription for a given participant and ranged from 20 to 75 minId j1 across the intervention. Energy expended during each exercise session ranged from 350 to 550 kcalId j1 and was quantified using the OwnCal feature (27) on the Polar S610 heart rate monitor (Polar Electro Oy, Kempele, Finland). This method was superior to the use of accelerometers to capture energy expended during modes of exercise, such as stationery cycling, elliptical, and treadmill running with a grade. These monitors were continually updated with the most recent values for participant weight, V O 2max , and age. Several different modes of exercise were utilized, including treadmill running, elliptical machine exercise, stair stepping, and stationary cycling. Accelerometers were removed after participants were equipped with heart rate monitors for a given exercise session and returned and worn when heart rate monitors were removed at the conclusion of an exercise session.
Anthropometrics. Body weight was measured to the nearest 0.01 kg using a digital scale (Seca, Hamburg, Germany) by a CRC dietitian. The CRC dietitian measured each participant_s body weight in the morning (before eating) twice per week while participants wore standard shorts and a tee shirt. Body composition was measured during the first 7 d of baseline, INT 2, and INT 3 phases, and during the poststudy period using hydrostatic weighing after correcting for residual lung volume (28) .
Resting metabolic rate. Resting metabolic rate was measured in the early follicular phase between 6:00 AM and 10:00 AM after an overnight fast as previously published (29) . Upon arriving at the laboratory, the participant would lie in a supine position on a bed for 20 to 30 min to acclimate to room temperature and undergo familiarization with the equipment and procedures. A ventilated hood was then placed over the participant_s head for 30 min. Expired air was analyzed each minute for carbon dioxide and oxygen concentration using a carbon dioxide analyzer (URAS 4; Hartmann & Braun, Frankfurt, Germany) and a paramagnetic oxygen analyzer (Magnos 4G; Hartmann & Braun). The values for minutes in which steady state was achieved were averaged, and the RMR in kilocalories per minute was determined using the Weir equation (30).
Aerobic capacity. A laboratory technician measured V O 2max during the screening, baseline, INT 1, INT 2, and INT 3 phases, and during the poststudy period with an incremental treadmill test (modified Åstrand protocol (31)) to volitional fatigue using indirect calorimetry (Sensormedics metabolic cart model no. 229; Sensormedics Corp., Yorba Linda, CA).
Blood sampling. Screening blood samples were collected during the first week of the menstrual cycle between 7:00 AM and 10:00 AM in the CRC. Baseline blood samples were collected for 3 d during the middle of the luteal phase to confirm ovulation in real time during that cycle (the day of ovulation for the purposes of this analysis was measured with the use of urinary LH, as described below). A CRC nurse collected all blood samples after participants lay supine for 15 min and had fasted for 12 h. Samples were allowed to clot at room temperature and were then centrifuged for collection of serum.
Menstrual status and daily urine collection. Menstrual status was monitored with menstrual calendars and daily urine samples during baseline, INT 1, INT 2, and INT 3 cycles using previously published methods (23) . Menstrual calendars were kept by the participants who recorded the days of menstrual bleeding, the severity of bleeding, and the occurrence of cramps or other menstrual symptoms, that is, bloating and spotting. Follicular phase length was assessed as the number of days from the first day of menses to the day of ovulation; luteal phase length was assessed as the number of days from the day after ovulation to the day preceding the first occurrence of menses. Confirmation of ovulation, the presence or absence of MD, and the lengths of the follicular and luteal phases were assessed by analyzing daily urine samples for the urinary metabolites E1G, PdG, and LH. Menstrual disturbances that were identified included luteal phase defects, anovulation, and oligomenorrhea. Luteal phase defects were ovulatory menstrual cycles which had short luteal phases (G10 d) and/or inadequate luteal phases utilizing urinary PdG concentrations (peak PdG G5 KgImL j1 ) (1, 32) . Anovulatory cycles were cycles lacking an adequate preovulatory E1G peak, an absence of a midcycle LH surge, and no luteal rise in PdG above 2.49 KgImL j1 (1, 32) . Oligomenorrheic cycles were cycles that had a length of 36 or more days (21) .
Biochemical analyses. A complete blood count, chemistry panel, and an endocrine panel were completed by Quest Diagnostics (Lyndhurst, NJ). The endocrine panel included measurements of LH, follicle-stimulating hormone, prolactin, progesterone, estradiol, thyroxine, and thyroidstimulating hormone. Progesterone was measured in our laboratory using a radioimmunoassay on the serum samples obtained during the midluteal phase of the baseline cycle (Diagnostics Products Corporation, Los Angeles, CA). The sensitivity of the progesterone assay is 0.02 ngImL
j1
. The intra-assay and inter-assay coefficients of variation for the high controls were 2.7% and 3.9%, respectively; the intra-assay and inter-assay coefficients of variation for the low controls were 8.8% and 9.7%. Competitive enzyme immunoassays were used to measure the major urinary estrogen and progesterone metabolites, E1G and PdG, according to previously published methods (33) . Urinary LH was measured using a radioimmunoassay (Diagnostic Products Corporation). The sensitivity of the LH assay is 0.15 mIUImL
. The intraassay and inter-assay coefficients of variation for the high controls were 1.0% and 3.4%, respectively; the intra-assay and inter-assay coefficients of variation for the low controls were 1.6% and 7.1%. All biochemical analyses for a given participant were measured in the same assay, and all samples were run in duplicate.
Methods for the Current Analysis
Calculation of EA during the study's intervention phases. EA for a given day was quantified as:
Net EEE was calculated each exercise day by subtracting the energy expenditure that was attributable to RMR from the total EEE during the exercise period. EA was calculated on nonexercise days and EEE was assumed to be zero. The daily EA values were averaged for each study phase (INT 1, INT 2, INT 3). The above method to calculate EA is very similar to the method of Loucks et al. (15, 16) , although there is a slight difference. Loucks et al. (15, 16) 
j1 ffmId j1 difference in EA when EA was averaged over the whole intervention, with the calculations used in this analysis resulting in higher EA values. Because of this small difference, we believe our calculation of EA is comparable to that of Loucks et al. (15, 16) .
Statistical Analysis
All continuous variables were assessed for normality and the presence of outliers before any statistical analyses were performed. All PdG data and follicular and luteal phase length data were log transformed because the data were not normally distributed. We analyzed the data provided by participants (n = 35) who completed all phases of the study. We imputed the data (used INT 2 data for INT 2 and INT 3) collected on one participant who had a 59-d INT 2 cycle and had to leave the study due to other commitments. Specifically, this participant_s INT 2 cycle was repeated as her INT 3 cycle. Linear regression was used to compare participants_ mean percent energy deficit during the intervention with their calculated mean intervention EA. Analyses of anthropometric, V O 2max , EA, menstrual cycle length, E1G, and PdG data were conducted using one-between, one-within repeated-measures ANOVA, with participant EA group as the between-participant variable and time and the group-time interaction were the within-participant variables. Post hoc testing for group mean differences was performed using Fisher_s least significant difference (LSD). Post hoc testing for within-group changes in EA over time was completed with paired t-tests adjusted with the Bonferroni correction.
We fit a generalized linear mixed-effects model to test whether previous cycle (lag-1) and (or) current cycle EA were significant predictors of the presence of MD during each intervention phase (INT 1, INT 2, and INT 3) of the study. Previous cycle EA (lag-1) and current cycle EA were treated as fixed effects. The response variable was MD; it was coded as a 0/1 binary variable if it did not or did occur in a given cycle. The model was fit to data on all three cycles from all participants (35 participants, n = 105 observations). To account for the dependent data provided by each participant, participant identification number was incorporated into the model as a random effect. Data were analyzed using IBM SPSS Statistics for Windows Version 22.0, Armonk, NY.
RESULTS
Participants. Participants were healthy, sedentary (G1 h of purposeful exercise per week) women, age 18 to 24 yr. Participants_ baseline characteristics are presented in Table 1 .
Changes in EA. Changes in study phase EA by EA group are presented in Figure 1 . A one-between, onewithin repeated-measures ANOVA revealed significant time (P G 0.001), group (P G 0.001), and group-time effects (P = 0.041) for changes in study phase EA. Post hoc testing using paired t-tests adjusted with the Bonferroni correction revealed no significant change in EA in the high EA group; that EA decreased significantly from INT Anthropometrics and aerobic capacity. Changes in anthropometric and aerobic capacity data are presented in Table 2 . There were no statistically significant Baseline EA group mean differences with respect to body weight, BMI, FFM, percent body fat, fat mass, age of menarche, gynecological age, cycle length, or V O 2max . A one-between, onewithin repeated-measures ANOVA indicated that body weight decreased over time (P G 0.001); however, this decrease was not significantly different among EA groups. Percent change in weight was j5.7% T 1.3% in the low EA group, j4.1% T 1.1% in the moderate EA group, and j3.6% T 0.9% in the high EA group. Separate one-between, one-within repeated-measures ANOVA indicated that percent body fat, fat mass, and BMI all declined significantly over time (P G 0.001); however, these decreases were not significantly different among EA groups. In addition, a one-between, one-within repeated-measures ANOVA indicated aerobic capacity increased in all groups (P G 0.001); however, this increase was not significantly different among EA groups. Changes in menstrual cyclicity. A generalized linear mixed-effects model fit to MD revealed current cycle EA was a statistically significant predictor of the presence of a disturbance in a given menstrual cycle such that each unit decrease in EA was associated with a 9% increase (odds ratio, 0.91; 95% confidence interval, 0.84-0.98) in the likelihood of experiencing a MD (P = 0.010). Previous cycle EA (lag-1) was not a significant predictor of the presence of a MD in a given menstrual cycle. Overall, the sensitivity of the model was 40.0% (model correctly predicted the presence of a MD) and the specificity of the model was 82.5% (model correctly predicted the absence of a MD). Figure 2 represents the relation between EA, MD, and the EA threshold of kcalIkg j1 ffmId j1 previously demonstrated to disrupt LH pulsatility (16) . Of note is the frequent occurrence of MD above the threshold of 30 kcalIkg j1 ffmId j1 . Notably, when the results of our generalized linear mixedeffects model fit to MD are graphed, an EA of less than 30 kcalIkg j1 ffmId j1 is associated with a predicted probability of a MD exceeding 50%.
Luteal phase defects were the most common disturbance during the intervention (57% of total disturbances), followed by anovulation (28% of total disturbances). Oligomenorrheic cycles (15% of total disturbances) were the least common disturbance. A one-between, one-within repeated-measures ANOVA indicated that there was no change in cycle length or follicular phase length over time (P G 0.001); and that there was no difference in these lengths among EA groups. In addition, a one-between, one-within repeated-measures ANOVA indicated luteal phase length declined significantly over time (P = 0.031); however, this decrease was not significantly different among EA groups.
Urinary hormone concentrations. Table 3 presents changes in mean cycle, follicular, and luteal E1G and PdG by EA group during the four study phases. Figure 3 displays composite graphs representing changes in EA group urinary E1G, PdG, and LH concentrations during baseline and INT 3.
Separate one-between, one-within repeated-measures ANOVA indicated mean cycle E1G and PdG, and luteal PdG length declined significantly over time (P G 0.001); however, this decrease was not significantly different among EA groups. Finally, additional one-between, one-within repeated measures ANOVA analyses indicated that there were significant group effects for both follicular (P = 0.007) and luteal (P = 0.024) phase E1G. Fisher_s LSD post hoc test indicated follicular E1G concentrations were greater in the low EA group than in the Moderate EA group (P = 0.003), and luteal E1G was greater in the low EA group than in the high EA group (P = 0.007).
DISCUSSION
The major finding of this study was that EA calculated in a similar manner to that in short-term studies of changes in LH pulsatility was also a significant predictor of MD during a controlled, feeding-and-exercise intervention in previously untrained, normally menstruating, young women. This finding is important because consensus statements and position stands frequently incorporate the Loucks et al. index of EA into practical guidelines for prevention and treatment of the female athlete triad even though no experiments have established the significance of this index with respect to ovarian function per se (3, 21) . However, in contrast to the studies of LH pulsatility conducted by Loucks et al. (15, 16) , we observed no discernible EA threshold below which MD were initiated. As EA dropped below approximately 30 kcalIkg j1 ffmId j1 , the probability that a participant experienced a MD exceeded 50%. Finally, our diet-and-exercise intervention had a suppressive effect on E1G excretion and on PdG excretion during the intervention that was not dependent on EA.
This work expands on earlier work from our laboratory (20) which demonstrated that a diet-and-exercise intervention that produced varying levels of energy deficiency induced MD in a dose-dependent manner in previously untrained women. In the current study, we show that a particular calculation of EA that differs from the calculation of energy deficit used by Williams et al. (20) is also a significant predictor of MD. This finding is important because overall energy deficit can often be cumbersome to calculate in field settings due to the difficulties quantifying all three components of energy expenditure (RMR, nonexercise activity thermogenesis, and exercise expenditure). Energy availability is easier to calculate because it requires only the purposeful exercise component of 24-h energy expenditure (34) . Interestingly, our analysis showed that the average percent deficit calculated using all components of energy balance as in Williams et al. (20) was highly correlated with mean EA. This finding indicates that daily non-EEE and RMR remained fairly consistent when MD were newly induced with modest energy deficits created through the combination of energy restriction and exercise. Moreover, a 0% deficit was equivalent to an EA of approximately 45 kcalIkg j1 ffmId j1 which is assumed by Loucks et al. (34) to approximate energy balance. The relation between overall energy balance and EA calculated similarly to Loucks et al. has never been reported. This finding is important because it confirms that the EA calculation used by Loucks and replicated in this study provides a meaningful assessment of overall energy balance when used over several months. However, adaptations in components of energy expenditure to conserve energy for more vital bodily processes, such as a reduction in RMR, can occur over a sustained period of energy deficiency (35) . Such compensatory adaptations restore energy balance even though an individual is ''energy deficient'' relative to a healthy energy status (36) . The Loucks et al. calculation of EA for preventing and treating MD in an active population is particularly useful because it is unaffected by compensatory homeostatic mechanisms, such as decline in RMR, which can occur with severe energy deficits.
We observed that EA in a given study phase was a significant predictor of MD, whereas previous cycle EA was not. This finding is consistent with several studies using both animal and human models in that the effects of changes in EA occur rapidly (16, 37, 38) . After glucose deprivation in sheep, there was an almost immediate suppression of pituitary LH secretion (38) . Similarly, a 1-d fast of male Rhesus monkeys reduced both LH and testosterone pulse frequency (37) . The aforementioned work by Loucks et al. (15, 16) demonstrated reduced LH pulse frequency in young eumenorrheic women after 5 d of varying levels of low EA. Finally, in a previous study, Williams et al. (39) demonstrated that initiating strenuous exercise at the onset of a menstrual cycle could induce luteal phase dysfunction within the same menstrual cycle, and that exercise confined to the luteal phase could also induce luteal dysfunction. These findings demonstrate that the hypothalamic-pituitary-ovarian axis can be rapidly disrupted by low EA, whereas carryover effects of EA during the previous cycle appear to be minimal. Our results also support the established importance of readily available oxidative fuels versus energy stores in the induction of MD and help explain why MD can occur across a wide range of body fat levels (14, 40) .
Our inability to find an EA threshold that induces MD is consistent with a cross-sectional finding reported by Reed at al. (41) . The latter reported that the EA threshold of 30 kcalIkg j1 ffmId j1 could not distinguish eumenorrheic individuals from individuals with subclinical MD (i.e., luteal phase defect, anovulation). Similarly, Guebels et al. (42) showed that when EA was calculated using four different cutoffs of exercise intensity for the EEE that was subtracted from EI, EA was not different between amenorrheic and eumenorrheic women. Differences between our own findings and those of the short-term studies by Loucks may be due to several factors. A threshold may exist for the short-term effects of metabolic stressors on LH pulsatility but not for more chronic declines in gonadotropin support that would begin to impact ovarian , the predicted probability of experiencing a MD exceeded 50%.
Our study demonstrates the utility of the EA calculation in the prediction of MD. However, its use by practitioners or individuals outside a laboratory as a tool to make decisions about healthy dietary strategies is limited by the accuracy of methods to assess the components (i.e., dietary intake, EEE, and body composition). As well, the measure is best used in conjunction with other measures of EA, such as one_s history of and current eating behaviors and attitudes and history of body weight changes (3) . Multiple measures of EA in the same individual should be recommended to observe trends, and a target and sustained EA of kcalIkg j1 ffmId j1 is a wise recommendation to prevent clinical sequelae associated with the female athlete triad.
Of interest is the finding that exercise seemed to have a progressive inhibitory effect on reproductive hormone excretion. This finding is observed qualitatively in Figure 3 where there was a blunting of E1G, PdG, and LH excretion in the three EA groups as the intervention progressed. This overall decline in mean cycle concentrations of urinary E1G and PdG and mean luteal PdG concentrations was statistically significant for all groups. This finding extends reports from other studies which have shown that exercise has a suppressive effect on sex hormone concentrations in women (48, 49) . Specifically, the current study demonstrated that the effects of exercise on the menstrual cycle were independent of effects of EA.
Although our study provides important insights into the impact of EA on menstrual function, there are limitations to be considered. Our original study was not designed to test the effects of EA as calculated by Loucks et al. (16) on menstrual function, and thus our results rely on a secondary analysis of our original energy balance data. As well, our secondary analysis did not replicate the specific levels of EA studied by Loucks et al. (16) . Additionally, our measures of energy balance are associated with sources of potential error and variability. For example, participants may have consumed food outside the study. Although this could have impacted our EA calculations, we believe that the variability attributable to this is likely to be relatively modest because participants reported a high compliance to their respective energy prescriptions. The use of heart rate monitors to measure EEE is not as accurate when compared to indirect calorimetry (9) . Lastly, each EA group included participants with varying combinations of energy restriction and exercise prescriptions and thus subtle differences in effects on ovarian function due to how an energy deficit is created, (i.e., by exercise or energy restriction), cannot be discerned. Our study had many strengths including the randomized, prospective design, the control of both the dietary intake and exercise training, and the detailed characterizations of MD using daily urinary measures. Our secondary analysis included detailed and daily calculations of EA over the entire intervention using updated assessments of FFM and daily measures of actual dietary energy intake and EEE. There are currently no other reports of prospective laboratory studies testing the validity of EA calculations in association with exercise-related MD.
In conclusion, this study addresses an important gap in the literature by demonstrating the utility of a particular and relatively easy calculation of EA for assessing the risk of MD in active young women. Energy availability was a highly significant predictor of MD during the intervention, but a specific threshold for induction of menstrual disturbances was not demonstrated. Future studies should test whether EA predicts changes in menstrual status over an even longer period of time and should include the reversal of MD in amenorrheic and oligomenorrheic exercising women. Moreover, the utility of field as opposed to laboratory-based measurements of EA need to be validated as a means of identifying exercising women at risk for MD.
